-->

Tag: Phase 3 trial results

Home / Phase 3 trial results

Categories

Omidubicel is approved by USFDA to reduce time to neutrophil recovery and infection in patients with hematologic malignancies

May 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) was approved by the Food and Drug Administration for use in adult and paediatric patients (12 years of age and older) with hematologic malignanc...
phase-3-trial-results

Scan the code